Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

ChemoCentryx

ChemoCentryx is a privately held biopharma company specializing in the biology of chemokines, protein hormones that regulate the migration, or trafficking, of white blood cells around the body. White cell (leukocyte) trafficking is an essential process, regulating our response to infection and inflammation. While chemokines are important for normal health, the chemokines (and their receptors) compose a balanced but complicated system that is linked to diseases as diverse as rheumatoid arthritis, atherosclerosis, multiple sclerosis, and even AIDS.


Contact Details:
1539 Industrial Road
San Carlos
CA
94070
United States of America
Tel:650-632-2900
Fax:650-632-2910
Email:
WWW:

www.chemocentryx.com/




Loading...

Recent Publications by ChemoCentryx:

Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
CXCR7 binds chemokines CXCL11 (I-TAC) and CXCL12 (SDF-1) but does not act...
19th September, 2009
ChemoCentryx, J Immunol. 2009 Sep 1;183(5):3204-11. Epub 2009 Jul 29.
DOI Direct Link
CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature.
Chemokines and chemokine receptors have been posited to have important...
6th December, 2007
ChemoCentryx, Inc., Mountain View, CA 94043, USA. Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15735-40. Epub 2007 Sep 26.
DOI Direct Link
Proinflammatory proteases liberate a discrete high-affinity functional FPRL1 (CCR12) ligand from CCL23.
Most chemokines have been found to bind to and signal through single or...
13th July, 2007
ChemoCentryx, J Immunol. 2007 Jun 1;178(11):7395-404.
Evidence for NK cell subsets based on chemokine receptor expression.
To help understand the role of chemokines in NK cell trafficking, we...
17th January, 2007
ChemoCentryx, 850 Maude Avenue, Mountain View, CA 94043, USA. J Immunol. 2006 Dec 1;177(11):7833-40.
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development.
The chemokine stromal cell-derived factor (SDF-1; also known as chemokine...
9th November, 2006
ChemoCentryx, Inc., Mountain View, CA 94043, USA. J Exp Med. 2006 Sep 4;203(9):2201-13. Epub 2006 Aug 28.
DOI Direct Link

View more ChemoCentryx research publications.

Press Releases on ChemoCentryx:

BioPortfolio Logo
PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryx's Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference 1st June, 2009 ChemoCentryx, Inc.
Oral CCR9 Antagonist Demonstrates Clinical Efficacy with Favorable Tolerability Profile MOUNTAIN VIEW, Calif., June 1 /PRNewswire/ -- ChemoCentryx, Inc., announced that Phase II/III clinical data
ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 19th May, 2009 ChemoCentryx, Inc.
First-in-class Oral Therapeutic for IBD with Novel Mode of Action MOUNTAIN VIEW, Calif., May 19 /PRNewswire/ -- ChemoCentryx, Inc., today announced that data from the company's PROTECT-1 (the
ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist 5th May, 2009 ChemoCentryx, Inc.
Development Candidate Triggers Milestone Payment from GlaxoSmithKline MOUNTAIN VIEW, Calif., May 5 /PRNewswire/ -- ChemoCentryx, Inc., today announced that it has identified an orally
Solexa Names Linda Rubinstein Vice President And CFO 1st January, 1970 Solexa
Solexa Names Linda Rubinstein Vice President And CFO HAYWARD, Calif. (March 30, 2005) – Solexa, Inc. (NASDAQ: SLXA) today announced the

ChemoCentryx Clinical Trials:

A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease

ChemoCentryx Patents:

US Patent No.Title
7589199 Substituted piperazines
7262204 Modulation of CCR4 function
7253007 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
7227035 Bis-aryl sulfonamides
7157464 Substituted piperazines

View more ChemoCentryx patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 386 times since April 2007, the link to the organisation's website has been followed 71 times

Search for more companies in San Carlos

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for ChemoCentryx

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.